CF
ROIV icon

Centaurus Financial’s Roivant Sciences ROIV Stock Holding History

Centaurus Financial’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$126K Buy
+3,554
New +$105K ﹤0.01% 1025
2026
Q1 		– Sell
-12,237
Closed -$266K – 1122
2025
Q4 		$266K Buy
+12,237
New +$241K 0.01% 715

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Centaurus Financial's ROIV Position: Q2 2026 in Review

Centaurus Financial opened a new position in Roivant Sciences (ROIV) in Q2 2026: 3,554 shares worth $126K. The stake represents ﹤0.01% of the portfolio and ranks #1025 among its holdings. This is a return to the name: Centaurus Financial previously reported a position in ROIV as recently as Q4 2025.

Centaurus Financial first reported a position in ROIV in Q4 2025 and has held it in 2 quarters since. The position peaked at $266K in Q4 2025. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Centaurus Financial held 3,554 shares of Roivant Sciences worth $126K as of Q2 2026.
  • Roivant Sciences was a new Centaurus Financial position in Q2 2026.
  • Roivant Sciences made up ﹤0.01% of Centaurus Financial's portfolio in Q2 2026, its #1025 holding.
  • Centaurus Financial first reported a position in Roivant Sciences in Q4 2025 and has held it in 2 quarters since.
  • Centaurus Financial's Roivant Sciences position peaked at $266K in Q4 2025.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Centaurus Financial's 13F filing for Q2 2026, filed 17 Aug 2026.